(Circulation. 1996;93:1079-1082.)
© 1996 American Heart Association, Inc.
Articles |
From the Molecular/Cancer Biology Laboratory, Haartman Institute (K. Paavonen, K. Pajusola, D.C., E.K., V.J., K.A.), Helsinki, Finland; the Department of Clinical Chemistry (N.H-K., A.P.), Helsinki University Central Hospital, Helsinki, Finland; the Laboratory of Cancer Genetics (S.P., O.-P.K.), University of Tampere Institute of Medical Technology, Tampere, Finland; and Ludwig Institute for Cancer Research (B.O., U.E.), Stockholm Branch, Stockholm, Sweden.
Correspondence to Kari Alitalo, Molecular/Cancer Biology Laboratory, Haartman Institute, PO Box 21 (Haartmanninkatu 3), 00014 Helsinki, Finland. E-mail Kari.Alitalo@Helsinki.FI.
Background Vascular endothelial growth factor (VEGF) is an important regulator of endothelial cell proliferation, migration, and permeability during embryonic vasculogenesis as well as in physiological and pathological angiogenesis. The recently isolated VEGF-B and VEGF-C cDNAs encode novel growth factor genes of the VEGF family.
Methods and Results Southern blotting and polymerase chain reaction analysis of somatic cell hybrids and fluorescence in situ hybridization (FISH) of metaphase chromosomes were used to assess the chromosomal localization of VEGF-B and VEGF-C genes. The VEGF-B gene was found on chromosome 11q13, proximal to the cyclin D1 gene, which is amplified in a number of human carcinomas. However, VEGF-B was not amplified in several mammary carcinoma cell lines containing amplified cyclin D1. The VEGF-C gene was located on chromosome 4q34, close to the human aspartylglucosaminidase gene previously mapped to 4q34-35.
Conclusions The VEGF-B locus in 11q13 and the VEGF-C locus in 4q34 are candidate targets for mutations that lead to vascular malformations or cardiovascular diseases.
Key Words: growth substances genes cardiovascular diseases
This article has been cited by other articles:
![]() |
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet Role and Therapeutic Potential of VEGF in the Nervous System Physiol Rev, April 1, 2009; 89(2): 607 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Birk, J. Barbato, L. Mureebe, and R. A. Chaer Basic Science Review: Current Insights on the Biology and Clinical Aspects of VEGF Regulation Vascular and Endovascular Surgery, January 1, 2009; 42(6): 517 - 530. [Abstract] [PDF] |
||||
![]() |
J. Dai and A.B.M. Rabie VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification Journal of Dental Research, October 1, 2007; 86(10): 937 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Baldwin, S. Roufail, M. M. Halford, K. Alitalo, S. A. Stacker, and M. G. Achen Multiple Forms of Mouse Vascular Endothelial Growth Factor-D Are Generated by RNA Splicing and Proteolysis J. Biol. Chem., November 16, 2001; 276(47): 44307 - 44314. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Tabibiazar and S.G Rockson Angiogenesis and the ischaemic heart Eur. Heart J., June 1, 2001; 22(11): 903 - 918. [PDF] |
||||
![]() |
S. P. Gunningham, M. J. Currie, C. Han, B. A. Robinson, P. A. E. Scott, A. L. Harris, and S. B. Fox The Short Form of the Alternatively Spliced flt-4 but not Its Ligand Vascular Endothelial Growth Factor C Is Related to Lymph Node Metastasis in Human Breast Cancers Clin. Cancer Res., November 1, 2000; 6(11): 4278 - 4286. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kanellis, S. Fraser, M. Katerelos, and D. A. Power Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells Am J Physiol Renal Physiol, June 1, 2000; 278(6): F905 - F915. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R Kersten, P. S Pagel, W. M Chilian, and D. C Warltier Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia Cardiovasc Res, July 1, 1999; 43(1): 44 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reboul, K. Gardiner, D. Monneron, G. Uzé, and G. Lutfalla Comparative Genomic Analysis of the Interferon/Interleukin-10 Receptor Gene Cluster Genome Res., March 1, 1999; 9(3): 242 - 250. [Abstract] [Full Text] |
||||
![]() |
J. Condon, C. Gosden, D. Gardener, P. Nickson, M. Hewison, A. J. Howie, and P. M. Stewart Expression of Type 2 11{beta}-Hydroxysteroid Dehydrogenase and Corticosteroid Hormone Receptors in Early Human Fetal Life J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4490 - 4497. [Abstract] [Full Text] |
||||
![]() |
B. Witzenbichler, T. Asahara, T. Murohara, M. Silver, I. Spyridopoulos, M. Magner, N. Principe, M. Kearney, J.-S. Hu, and J. M. Isner Vascular Endothelial Growth Factor-C (VEGF-C/VEGF-2) Promotes Angiogenesis in the Setting of Tissue Ischemia Am. J. Pathol., August 1, 1998; 153(2): 381 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Nicosia What Is the Role of Vascular Endothelial Growth Factor-Related Molecules in Tumor Angiogenesis? Am. J. Pathol., July 1, 1998; 153(1): 11 - 16. [Full Text] [PDF] |
||||
![]() |
D. Chilov, E. Kukk, S. Taira, M. Jeltsch, J. Kaukonen, A. Palotie, V. Joukov, and K. Alitalo Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C J. Biol. Chem., October 3, 1997; 272(40): 25176 - 25183. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |